Galera Therapeutics, Inc. ( GRTX) - Stock Earnings
GRTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -1.1 million USD | — USD |
| 2025Q3 | -1.4 million USD | — USD |
| 2025Q4 | 153.1 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
GRTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.1 million USD | — USD |
| 2024 | -19.0 million USD | — USD |
| 2025 | 149.0 million USD | — USD |
| 2025 Est. | — | — |
GRTX
Price: $0.09
52 week price:
Earnings Per Share: 0.64 USD
P/E Ratio: 0.16
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 52746
Market Capitalization: 7.6 million